Smead Capital Management’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Buy
633,773
+23,079
+4% +$848K 0.47% 28
2026
Q1
$21.4M Buy
610,694
+23,965
+4% +$732K 0.47% 28
2025
Q4
$12.9M Sell
586,729
-3,537
-0.6% -$82.7K 0.27% 28
2025
Q3
$13.5M Hold
590,266
0.26% 30
2025
Q2
$9.75M Sell
590,266
-94,804
-14% -$1.61M 0.2% 29
2025
Q1
$10M Sell
685,070
-9,374
-1% -$155K 0.17% 31
2024
Q4
$9.55M Buy
694,444
+23,863
+4% +$447K 0.15% 31
2024
Q3
$15.2M Buy
670,581
+32,531
+5% +$766K 0.22% 28
2024
Q2
$16.7M Buy
638,050
+23,324
+4% +$594K 0.26% 29
2024
Q1
$14M Buy
614,726
+113,899
+23% +$2.57M 0.22% 29
2023
Q4
$10M Buy
500,827
+13,376
+3% +$276K 0.18% 30
2023
Q3
$8.98M Buy
487,451
+18,582
+4% +$313K 0.18% 28
2023
Q2
$6.75M Buy
468,869
+3,548
+0.8% +$53K 0.13% 28
2023
Q1
$7.61M Buy
+465,321
New +$7.32M 0.15% 29
2022
Q4
Sell
-311,195
Closed -$3.45M 27
2022
Q3
$3.45M Buy
311,195
+14,290
+5% +$157K 0.09% 26
2022
Q2
$2.66M Buy
+296,905
New +$2.69M 0.07% 29

Other funds holding FRO

Smead Capital Management's FRO Position: Q2 2026 in Review

Smead Capital Management increased its Frontline (FRO) stake by 3.8% in Q2 2026, buying an estimated $848K and bringing the position to 633,773 shares worth $22M. The position accounts for 0.47% of the portfolio, ranked #28.

Smead Capital Management first reported a position in FRO in Q2 2022 and has held it in 16 quarters since. 261 funds tracked by Wall St. Rank hold FRO as of Q2 2026.

  • Smead Capital Management held 633,773 shares of Frontline worth $22M as of Q2 2026.
  • Smead Capital Management bought 23,079 Frontline shares in Q2 2026, an estimated $848K.
  • Frontline made up 0.47% of Smead Capital Management's portfolio in Q2 2026, its #28 holding.
  • Smead Capital Management first reported a position in Frontline in Q2 2022 and has held it in 16 quarters since.
  • 261 funds tracked by Wall St. Rank held Frontline as of Q2 2026.

Based on Smead Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.